On February 1, the USITC formally announced the opening of its investigation into the merits of expanding the TRIPS Waiver to diagnostics and treatments. The investigation was initially requested by USTR, who had been leading...more
Key Points -
On December 6, days before a deadline for WTO members to decide whether to expand the TRIPS waiver for COVID-19 vaccines to cover COVID-19 diagnostics and therapeutics as well, the Office of the USTR...more
12/9/2022
/ Biden Administration ,
Coronavirus/COVID-19 ,
Intellectual Property Protection ,
International Trade Commission (ITC) ,
Onshoring ,
Patents ,
Pharmaceutical Industry ,
Pharmaceutical Patents ,
Prescription Drugs ,
TRIPS Agreement ,
Vaccinations ,
Waivers ,
WTO
For several years, policy-makers and commentators have expressed concern about the resilience of the United States’ pharmaceutical supply chain. Current U.S.-based manufacturing capabilities have been at the forefront of...more
10/8/2021
/ Biden Administration ,
Biomedical Advanced Research and Development Authority (BARDA) ,
China ,
Competition ,
Coronavirus/COVID-19 ,
Defense Production Act ,
Department of Defense (DOD) ,
Department of Health and Human Services (HHS) ,
Food and Drug Administration (FDA) ,
Life Sciences ,
Manufacturers ,
NDAA ,
Pharmaceutical Industry ,
Supply Chain
In this new episode of OnAir: Health Care, Akin Gump health care senior policy advisor Matthew Hittle and consultant Dr. Mario Ramirez welcome Akin Gump public law and policy partner Clete Willems and Centrient...more
8/5/2021
/ Biden Administration ,
Coronavirus/COVID-19 ,
Intellectual Property Protection ,
Manufacturers ,
Onshoring ,
Patents ,
Pharmaceutical Industry ,
Pharmaceutical Patents ,
Prescription Drugs ,
Supply Chain ,
Trade Secrets ,
TRIPS Agreement ,
Vaccinations ,
Waivers ,
WTO
In this new episode of OnAir: Health Care, Akin Gump health care senior policy advisor Matthew Hittle and consultant Dr. Mario Ramirez welcome public law and policy partners Ed Pagano and Clete Willems to talk federal health...more
4/16/2021
/ American Rescue Plan Act of 2021 ,
Biden Administration ,
Budget Reconciliation ,
Centers for Disease Control and Prevention (CDC) ,
Coronavirus/COVID-19 ,
Health Care Providers ,
Hospitals ,
Infectious Diseases ,
Infrastructure ,
Intellectual Property Protection ,
Legislative Agendas ,
New Guidance ,
Pharmaceutical Industry ,
Pharmaceutical Patents ,
Physicians ,
Public Health ,
Public Policy ,
Vaccinations
On January 15, 2020, the United States and China signed a Phase 1 trade agreement (the “Agreement”). The Agreement addresses a broad range of economic issues including intellectual property, agriculture, financial markets,...more